FAKTOR-ZERTIFIKAT - BOSTON SCIENTIFIC | Market Closed - Börse Stuttgart 15:49:33 2024-06-20 EDT | ||
| 7.62 EUR | -3.54% |
|
| Current month | -11.91% | ||
| 1 month | -11.29% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BOSTON SCIENTIFIC CORPORATION
| Date | Price | Change |
|---|---|---|
| 24-06-20 | 7.62 | -3.54% |
| 24-06-19 | 7.9 | +0.64% |
| 24-06-18 | 7.85 | -2.00% |
| 24-06-17 | 8.01 | +4.71% |
| 24-06-14 | 7.65 | +0.79% |
Delayed Quote Börse Stuttgart
Last update June 20, 2024 at 03:49 pm
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | BOSTON SCIENTIFIC CORPORATION |
| Issuer | J.P. Morgan |
| WKN | JK7YQG |
| ISIN | DE000JK7YQG4 |
| Date issued | 2024-04-26 |
| Strike | 91.57 $ |
| Maturity | Unlimited |
| Parity | 1.86 : 1 |
| Emission price | 10.03 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.53 € |
|---|---|
| Lowest since issue | 7.13 € |
| Spread | 0.3 € |
| Spread % | 3.81% |
Company Profile
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Sector
-
Ratings for Boston Scientific Corporation
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Boston Scientific Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
77
USD
Average target price
82.26
USD
Spread / Average Target
+6.83%
- Stock Market
- Certificates
- Certificat
